Effect of SIMBRINZA™ As an Added Therapy to a Prostaglandin Analogue
Conditions: Ocular Hypertension; Open Angle GlaucomaInterventions: Drug: Brinzolamide 1%/brimonidine 0.2% ophthalmic suspension; Drug: Vehicle; Drug: Prostaglandin analogue ( TRAVATAN Z® , LUMIGAN®, XALATAN®)Sponsors: Alcon Research; Alcon ResearchNot yet recruiting - verified September 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials